Rocket Pharmaceuticals Stock Forecast

Buy candidate since Jul 17, 2026

The Rocket Pharmaceuticals Inc stock price gained 0.88% on the last trading day (Friday, 17th Jul 2026), rising from $3.41 to $3.44. During the last trading day the stock fluctuated 5.67% from a day low at $3.26 to a day high of $3.45. The price has been going up and down for this period, and there has been a -10.42% loss for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 81 thousand more shares were traded than the day before. In total, 1 million shares were bought and sold for approximately $5.10 million.

The stock is moving within a very wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect Rocket Pharmaceuticals Inc stock with a 90% probability to be traded between $2.64 and $4.28 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

RCKT Signals & Forecast

The Rocket Pharmaceuticals Inc stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $3.71. On a fall, the stock will find some support from the long-term average at approximately $3.29. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, July 08, 2026, and so far it has fallen -18.87%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Rocket Pharmaceuticals Inc stock

Rocket Pharmaceuticals Inc finds support from accumulated volume at $3.35 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.185 between high and low, or 5.67%. For the last week, the stock has had daily average volatility of 5.23%.

Our recommended stop-loss: $3.24 (-5.90%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 7 days ago.)

Trading Expectations (RCKT) For The Upcoming Trading Day Of Monday 20th

For the upcoming trading day on Monday, 20th we expect Rocket Pharmaceuticals Inc to open at $3.38, and during the day (based on 14 day Average True Range), to move between $3.32 and $3.56, which gives a possible trading interval of +/-$0.232 (+/-6.98%) up or down from last closing price. If Rocket Pharmaceuticals Inc takes out the full calculated possible swing range there will be an estimated 6.98% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $3.52 (2.33%) than the support at $3.35 (2.62%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Rocket Pharmaceuticals Inc stock A Buy?

Several short-term signals are positive and we conclude that the current level may hold a buying opportunity, as there is a fair chance for Rocket Pharmaceuticals Inc stock to perform well in the short-term period. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.

Current score: 1.030 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on July 20, 2026 - $3.38 ( 1.70%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk